Submit Feedback
Learn more about Moderna's Revenue by Segment and Revenue by Region.
Check out competitors to Moderna in a side-by-side comparison.
Explore additional financial metrics for Moderna.
| 2018 | -506228.94736842 |
|---|---|
| 2019 | -619302.40963855 |
| 2020 | -574664.61538462 |
| 2021 | 4519259.2592593 |
| 2022 | 2144102.5641026 |
| 2023 | -841785.71428571 |
| 2024 | -613965.51724138 |
| 2025 | -600425.53191489 |
Moderna's net income per employee was -$600.43 K in fiscal year 2025.
Moderna's net income per employee was -$613.97 K in fiscal year 2024.
Moderna's net income per employee was -$841.79 K in fiscal year 2023.
Moderna's net income per employee was $2.14 M in fiscal year 2022.
Moderna's net income per employee was $4.52 M in fiscal year 2021.
Moderna's net income per employee was -$574.66 K in fiscal year 2020.
Moderna's net income per employee was -$619.30 K in fiscal year 2019.
| 2019 | 22.34 |
|---|---|
| 2020 | -7.21 |
| 2021 | -886.42 |
| 2022 | -52.56 |
| 2023 | -139.26 |
| 2024 | -27.06 |
| 2025 | -2.21 |
Moderna's net income per employee
decreased
-2.21% during fiscal year 2025 compared to
2024.
It represents a decline of
$13.54 K from
-$613.97 K (in
2024) to
-$600.43 K (in
2025).
Moderna's net income per employee
decreased
-27.06% during fiscal year 2024 compared to
2023.
It represents a decline of
$227.82 K from
-$841.79 K (in
2023) to
-$613.97 K (in
2024).
Moderna's net income per employee
decreased
-139.26% during fiscal year 2023 compared to
2022.
It represents a decline of
-$2.99 M from
$2.14 M (in
2022) to
-$841.79 K (in
2023).
Moderna's net income per employee
decreased
-52.56% during fiscal year 2022 compared to
2021.
It represents a decline of
-$2.38 M from
$4.52 M (in
2021) to
$2.14 M (in
2022).
Moderna's net income per employee
decreased
-886.42% during fiscal year 2021 compared to
2020.
It represents a decline of
$5.09 M from
-$574.66 K (in
2020) to
$4.52 M (in
2021).
Moderna's net income per employee
decreased
-7.21% during fiscal year 2020 compared to
2019.
It represents a decline of
$44.64 K from
-$619.30 K (in
2019) to
-$574.66 K (in
2020).
Moderna's net income per employee
increased
22.34% during fiscal year 2019 compared to
-.
It represents an increase of
-$113.07 K from
-$506.23 K (in
2018) to
-$619.30 K (in
2019).
| Period | Net Income per Employee | Year-over-Year Change |
|---|---|---|
| 2025 | -$600.43 K |
$13.54 K
2.21%
|
| 2024 | -$613.97 K |
$227.82 K
27.06%
|
| 2023 | -$841.79 K |
-$2.99 M
139.26%
|
| 2022 | $2.14 M |
-$2.38 M
52.56%
|
| 2021 | $4.52 M |
$5.09 M
886.42%
|
| 2020 | -$574.66 K |
$44.64 K
7.21%
|
| 2019 | -$619.30 K |
-$113.07 K
22.34%
|
Agilent Technologies Net Income per Employee
Eli Lilly and Company Net Income per Employee
Stryker Corporation Net Income per Employee
Johnson & Johnson Net Income per Employee
AbbVie Net Income per Employee
Merck & Co. Net Income per Employee
Thermo Fisher Scientific Net Income per Employee
Abbott Laboratories Net Income per Employee
Danaher Corporation Net Income per Employee
